We are live on ! Find out more
RXD icon

ProShares UltraShort Health Care

4 hedge funds and large institutions have $350K invested in ProShares UltraShort Health Care in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,839% more capital invested

Capital invested by funds: $18.1K → $350K (+$332K)

91% more call options, than puts

Call options by funds: $120M | Put options by funds: $62.7M

33% more funds holding

Funds holding: 34 (+1)

5.26% more ownership

Funds ownership: 0.6%5.85% (+5.3%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
Calls
$120M
Puts
$62.7M
Net Calls
+$57.1M
Net Calls Change
+$11.2M

Top Buyers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$332K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$5.96K
2
Simplex Trading
Simplex Trading
Illinois
-$77

RXD Hedge Fund Activity: Q1 2023 in Review

4 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q1 2023, worth a combined $350K — up 1,839% from $18.1K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new RXD positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $332K. The largest seller was UBS Group, cutting an estimated $5.96K.

  • 4 institutional investors held ProShares UltraShort Health Care (RXD) as of Q1 2023, up from 3 in Q4 2022.
  • Funds reported $350K of ProShares UltraShort Health Care stock for Q1 2023, up 1,839% quarter-over-quarter.
  • 1 fund opened new ProShares UltraShort Health Care positions in Q1 2023 and 0 closed out, a net change of +1 holder.
  • The largest ProShares UltraShort Health Care buyer in Q1 2023 was Envestnet Asset Management, an estimated $332K added.
  • The largest ProShares UltraShort Health Care seller in Q1 2023 was UBS Group, an estimated $5.96K sold.

Based on aggregated 13F filings for Q1 2023.